The global digital pathology market was valued at an estimated $250.2 million in 2013 and is expected to grow at a CAGR of 11.8%, to reach an estimated $437 million by 2018.

In 2013, the North American market was valued at $128.9 million and accounted for the largest share of the global digital pathology market, followed by Europe and Asia. The North American market is expected to grow at a healthy growth rate over the next five years. This high growth can be attributed to the favorable reimbursement scenario in the U.S. and the use of digital pathology to improve the quality of cancer diagnosis in Canada. However, lack of FDA approvals for digital pathology to be used for primary diagnosis acts as a major barrier for the North American market.

The European region has gained momentum for digital pathology. Some of the European countries have witnessed successful pathology projects which are likely to lead to higher adoption of digital pathology in these countries. Furthermore, Europe hosts various digital pathology conferences that aim to bring professionals under one roof and bring to light the ongoing developments in digital pathology. However, the Asian market, slated at an estimated CAGR of 13.7%, will experience the highest growth in the digital pathology market. The rise in awareness of digital pathology and its benefits, collaborative efforts by players, and federal health departments encouraging the use of digital pathology to improve the quality of cancer diagnosis are some of the factors driving the growth of the Asian market.

The major players in this market include 3DHistech (Hungary), Leica Biosystems (Germany), Ventana Medical Systems (U.S.), Hamamatsu Photonics K.K. (Japan), Mikroscan Technologies (U.S.), Definiens AG (Germany), Visiopharm (Denmark), and Indica Labs (U.S.).

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Secondary Research
1.5.2 Primary Research
1.5.3 Market Forecast
1.5.4 Market Data Validation and Data Triangulation
1.6 Assumptions

2 Executive Summary

3 Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.1.1 Rising Prevalence of Cancer
3.1.1.2 Improvement in Lab Efficiency
3.1.1.3 Drug Development
3.1.1.4 Increasing Use of Companion Diagnostics
3.1.1.5 Ease of Consultation Enabled By Digital Pathology
3.1.2 Restraints
3.1.2.1 High Cost of Digital Pathology Systems
3.1.2.2 Regulatory Concerns
3.1.2.3 Conservative Outlook of Pathologists
3.1.3 Opportunities
3.1.3.1 Digital Pathology to Help Combat the Shortage of Pathologists
3.1.3.2 Affordable Scanners for Private Pathology Practices
3.1.3.3 Biopharmaceutical and Drug toxicology Studies
3.1.3.4 Personalized Medicine
3.1.3.5 Digital Pathology to Aid Collaborations Between Asia and the West
3.2 Market Share Analysis
3.2.1 Digital Pathology Market, By Key Player
3.3 Industry Speaks

4 Digital Pathology: Rationale for Adoption
4.1 Introduction
4.2 Advantages of Digital Pathology
4.2.1 Geographic Distribution of Pathologists
4.2.2 Case Transport
4.2.3 Case Review
4.2.4 Additional Studies
4.2.5 Diagnosis Entry
4.2.6 Quality Control
4.3 Why A Lab Should Adopt Digital Pathology Technology

5 Global Digital Pathology Market, By Product
5.1 Introduction
5.2 Scanners
5.3 Analytics
5.3.1 Visualization Software
5.3.2 Digital Pathology Information Management Systems
5.3.3 Image Analysis Platforms
5.4 Storage
5.5 Communication/Delivery Modes
5.5.1 Web-Based
5.5.2 Cloud-Based

6 Global Digital Pathology Market, By Application
6.1 Introduction
6.2 Human Pathology
6.2.1 Pharmaceutical & Biotechnology Companies
6.2.2 Hospitals/Reference Laboratories/Academic Medical Centers (AMC)
6.2.3 Training and Education
6.3 Animal Pathology
6.3.1 Pharmaceutical & Biotechnology Companies
6.3.2 Academic & Government Research Institutes
6.3.3 Contract Research Organizations

7 Geographic Analysis
7.1 Introduction
7.2 North America
7.2.1 U.S.
7.2.1.1 Favorable Reimbursement Scenario for Digital Pathology in the U.S. to Boost the Market
7.2.2 Canada
7.2.2.1 Embracing Digital Pathology to Improve the Quality of Healthcare in Canada
7.3 Europe
7.3.1 U.K.
7.3.1.1 Technological Developments in the U.K. to Propel the Market
7.3.1.2 Conferences in the U.K. to Boost the Market
7.3.2 Germany
7.3.2.1 Conferences in Germany to Trigger Growth
7.3.3 Italy
7.3.3.1 Successful Digital Pathology Projects in Italy
7.3.4 France
7.3.4.1 Use of Digital Pathology in the Pharmaceutical Industry to Boost the Market in France
7.3.5 Spain
7.3.5.1 Adoption of Digital Pathology to Improve Quality of Healthcare
7.3.6 Denmark
7.3.6.1 Alarming Rise in Prevalence of Cancer to Boost the Market in Denmark
7.3.7 Norway
7.3.7.1 Digital Pathology Revolution in Norway to Propel Market Growth
7.3.8 Sweden
7.3.8.1 Conferences in Sweden to Boost the Market
7.3.8.2 Positive Funding Scenario in Sweden to Focus on innovation
7.3.9 Rest of Europe (ROE)
7.3.9.1 Digital Pathology Gaining Momentum in Netherlands
7.4 Asia
7.4.1 China
7.4.1.1 Collaborations in China to Boost the Market Growth
7.4.1.2 Ministry of Health in China Encourages Use of Digital Pathology
7.4.2 Japan
7.4.2.1 Focus on Stomach Cancer Diagnosis to Propel the Market in Japan
7.4.3 India
7.4.3.1 Digital Pathology Gaining Momentum in India
7.4.4 Rest of Asia (ROA)
7.4.4.1 Bilateral Agreements Aimed to Increase Awareness in Pakistan
7.5 Rest of the World (ROW)
7.5.1 Latin America
7.5.1.1 Players Eyeing Brazil As An Attractive Market
7.5.2 Africa
7.5.2.1 Strategies By Key Players to Aid Growth in Africa
7.5.3 Russia
7.5.3.1 Increasing Popularity of Digital Pathology As A Cost-Effective Solution to Help Propel the Market in Russia
7.5.4 Middle East
7.5.4.1 Exhibitions in the Middle East to Increase Awareness
7.5.5 Pacific Countries
7.5.5.1 Patients in the Pacific Countries to Receive Better and Timely Diagnosis Due to Digital Pathology

8 Competitive Landscape
8.1 Introduction
8.2 New Product Launches
8.3 Agreements, Partnerships, and Collaborations
8.4 Acquisitions
8.5 Other Developments

9 Company Profiles
9.1 3dhistech Ltd.
9.1.1 Business Overview
9.1.2 Source: Company Website
9.1.3 Product Portfolio
9.1.4 Key Strategy
9.1.5 Recent Developments
9.2 Apollo Pacs, Inc.
9.2.1 Business Overview
9.2.2 Products & Services
9.2.3 Key Strategy
9.2.4 Recent Developments
9.3 Aurora Interactive Ltd.
9.3.1 Business Overview
9.3.2 Product Portfolio
9.3.3 Key Strategy
9.3.4 Recent Developments
9.4 Corista LLC
9.4.1 Business Overview
9.4.2 Product Portfolio
9.4.3 Key Strategy
9.4.4 Recent Developments
9.5 Definiens AG
9.5.1 Business Overview
9.5.2 Product Portfolio
9.5.3 Key Strategy
9.5.4 Recent Developments
9.6 Digipath, Inc.
9.6.1 Business Overview
9.6.2 Product Portfolio
9.6.3 Key Strategy
9.6.4 Recent Developments
9.7 Hamamatsu Photonics K.K.
9.7.1 Business Overview
9.7.2 Company Snapshot
9.7.3 Products & Services
9.7.4 Key Strategy
9.7.5 Recent Developments
9.8 Huron Technologies International, Inc.
9.8.1 Business Overview
9.8.2 Products & Services
9.8.3 Key Strategy
9.8.4 Recent Developments
9.9 Indica Labs, Inc.
9.9.1 Business Overview
9.9.2 Product Portfolio
9.9.3 Key Strategy
9.9.4 Recent Developments
9.10 Kanteron Systems
9.10.1 Business Overview
9.10.2 Products & Services
9.10.3 Key Strategy
9.10.4 Recent Developments
9.11 Leica Biosystems, Gmbh
9.11.1 Business Overview
9.11.2 Product Portfolio
9.11.3 Key Strategy
9.11.4 Recent Developments
9.12 Ligolab, LLC
9.12.1 Business Overview
9.12.2 Products & Services
9.12.3 Key Strategy
9.12.4 Recent Developments
9.13 Mikroscan Technologies, Inc.
9.13.1 Business Overview
9.13.2 Products & Services
9.13.3 Key Strategy
9.13.4 Recent Developments
9.14 Nikon Instruments, Inc.
9.14.1 Business Overview
9.14.2 Products Portfolio
9.14.3 Key Strategy
9.14.4 Recent Developments
9.15 Objective Pathology Services, Ltd.
9.15.1 Business Overview
9.15.2 Products Portfolio
9.15.3 Key Strategy
9.15.4 Recent Developments
9.16 Omnyx, LLC
9.16.1 Business Overview
9.16.2 Product Portfolio
9.16.3 Key Strategy
9.16.4 Recent Developments
9.17 Xifin, Inc.
9.17.1 Business Overview
9.17.2 Products Portfolio
9.17.3 Key Strategy
9.17.4 Developments
9.18 Pathxl, Ltd.
9.18.1 Business Overview
9.18.2 Products & Services
9.18.3 Key Strategy
9.18.4 Recent Developments
9.19 Pixcelldata, Ltd.
9.19.1 Business Overview
9.19.2 Product Portfolio
9.19.3 Key Strategy
9.19.4 Developments
9.20 Sunquest Information Systems, Inc.
9.20.1 Business Overview
9.20.2 Product Portfolio
9.20.3 Strategy
9.20.4 Recent Developments
9.21 Ventana Medical Systems, Inc.
9.21.1 Overview
9.21.2 Products & Services
9.21.3 Key Strategy
9.21.4 Recent Developments
9.22 Visiopharm
9.22.1 Business Overview
9.22.2 Products & Services
9.22.3 Key Strategy
9.22.4 Recent Developments

List of Tables

Table 1 Key Data Points From Primary Sources
Table 2 Typical Laboratory Workflow Steps With Integrated Digital Imaging
Table 3 Global Digital Pathology Market Size, By Product, 2013–2018 ($Million)
Table 4 Market for Scanners, By Region, 2013–2018 ($Million)
Table 5 Market for Analytics, By Region, 2013–2018 ($Million)
Table 6 Market for Storage, By Region, 2013–2018 ($Million)
Table 7 Market for Communication/Delivery Modes, By Region, 20103–2018 ($Million)
Table 8 Global Market for Communication/ Delivery Mode, By Type, 2013–2018 ($Million)
Table 9 Digital Pathology Market for Web-Based Communication, By Region, 2013–2018 ($Million)
Table 10 Market for Cloud-Based Communication, By Region, 2013–2018 ($Million)
Table 11 Global Digital Pathology Market Size, By Application, 2011–2018 ($Million)
Table 12 Global Human Pathology Market Size, By Application, 2011–2018 ($Million)
Table 13 Human Pathology Market Size, By Region, 2011–2018 ($Million)
Table 14 Human Pathology Market for Pharmaceutical and Biotechnology Companies, By Region, 2011–2018 ($Million)
Table 15 Human Pathology Market for Hospitals/Reference Laboratories/Academic Medical Centers (AMC), By Region, 2011–2018 ($Million)
Table 16 Human Pathology Market for Training and Education, By Region, 2011–2018 ($Million)
Table 17 Global Animal Pathology Market Size, By Application, 2011–2018 ($Million)
Table 18 Animal Pathology Market Size, By Region, 2011–2018 ($Million)
Table 19 Animal Pathology Market for Pharmaceutical & Biotechnology Companies, By Region, 2011–2018 ($Million)
Table 20 Animal Pathology Market for Academic and Government Research Institutes, By Region, 2011–2018 ($Million)
Table 21 Animal Pathology Market for Contract Research Organizations, By Region, 2011–2018 ($Million)
Table 22 Digital Pathology Market Size, By Region, 2011–2018 ($Million)
Table 23 North America: Digital Pathology Market Size, By Product, 2011–2018 ($Million)
Table 24 North America: Market Size, By Application, 2011–2018 ($Million)
Table 25 North America: Market Size, By Country, 2011–2018 ($Million)
Table 26 U.S.: Digital Pathology Market Size, By Product, 2011–2018 ($Million)
Table 27 U.S.: Market Size, By Application, 2011–2018 ($Million)
Table 28 Canada: Digital Pathology Market Size, By Product, 2011–2018 ($Million)
Table 29 Canada: Market Size, By Application, 2011–2018 ($Million)
Table 30 Europe: Market Size, By Product, 2011–2018 ($Million)
Table 31 Europe: Market Size, By Application, 2011–2018 ($Million)
Table 32 Europe: Market Size, By Country, 2011–2018 ($Million)
Table 33 U.K.: Market Size, By Product, 2011–2018 ($Million)
Table 34 U.K.: Market Size, By Application, 2011–2018 ($Million)
Table 35 Germany: Market Size, By Product, 2011–2018 ($Million)
Table 36 Germany: Market Size, By Application, 2011–2018 ($Million)
Table 37 Italy: Market Size, By Product, 2011–2018 ($Million)
Table 38 Italy: Market Size, By Application, 2011–2018 ($Million)
Table 39 France: Digital Pathology Market Size, By Product, 2011–2018 ($Million)
Table 40 France: Market Size, By Application, 2011–2018 ($Million)
Table 41 Spain: Digital Pathology Market Size, By Product, 2011–2018 ($Million)
Table 42 Spain: Market Size, By Application, 2011–2018 ($Million)
Table 43 Denmark: Market Size, By Product, 2011–2018 ($Million)
Table 44 Denmark: Market Size, By Application, 2011–2018 ($Million)
Table 45 Norway: Market Size, By Product, 2011–2018 ($Million)
Table 46 Norway: Market Size, By Application, 2011–2018 ($Million)
Table 47 Sweden: Market Size, By Product, 2011–2018 ($Million)
Table 48 Sweden: Market Size, By Application, 2011–2018 ($Million)
Table 49 ROE: Digital Pathology Market Size, By Product, 2011–2018 ($Million)
Table 50 ROE: Market Size, By Application, 2011–2018 ($Million)
Table 51 Asia: Market Size, By Product, 2011–2018 ($Million)
Table 52 Asia: Market Size, By Application, 2011–2018 ($Million)
Table 53 Asia: Digital Pathology Market Size, By Country, 2011–2018 ($Million)
Table 54 China: Market Size, By Product, 2011–2018 ($Million)
Table 55 China: Market Size, By Application, 2011–2018 ($Million)
Table 56 Japan: Digital Pathology Market Size, By Product, 2011–2018 ($Million)
Table 57 Japan: Market Size, By Application, 2011–2018 ($Million)
Table 58 India: Market Size, By Product, 2011–2018 ($Million)
Table 59 India: Market Size, By Application, 2011–2018 ($Million)
Table 60 ROA: Market Size, By Product, 2011–2018 ($Million)
Table 61 ROA: Market Size, By Application, 2011–2018 ($Million)
Table 62 ROW: Market Size, By Product, 2011–2018 ($Million)
Table 63 ROW: Market Size, By Application, 2011–2018 ($Million)
Table 64 ROW: Market Size, By Region, 2011–2018 ($Million)
Table 65 Latin America: Digital Pathology Market Size, By Product, 2011–2018 ($Million)
Table 66 Latin America: Market Size, By Application, 2011–2018 ($Million)
Table 67 Africa: Market Size, By Product, 2011–2018 ($Million)
Table 68 Africa: Market Size, By Application, 2011–2018 ($Million)
Table 69 Russia: Digital Pathology Market Size, By Product, 2011–2018 ($Million)
Table 70 Russia: Market Size, By Application, 2011–2018 ($Million)
Table 71 Middle East: Digital Pathology Market Size, By Product, 2011–2018 ($Million)
Table 72 Middle East: Market Size, By Application, 2011 – 2018 ($Million)
Table 73 Pacific Countries: Market Size, By Product, 2011–2018 ($Million)
Table 74 Pacific Countries: Market Size, By Application, 2011–2018 ($Million)
Table 75 New Product Launches, 2011-2014
Table 76 Agreements, Partnerships, and Collaborations, 2011–2014
Table 77 Acquisitions, 2011–2014
Table 78 Other Developments, 2011–2014

List of Figures

Figure 1 Market Size Estimation Methodology
Figure 2 Market Sizing (Value Analysis)
Figure 3 Competitive Assessment (Market Share/Strategies Assessment)
Figure 4 Market forecasting Model
Figure 5 Data Triangulation Methodology
Figure 6 Global Digital Pathology Market Size, By Product, 2013–2018 ($Million)
Figure 7 Global Market Size, By Geography, 2013–2018 ($Million)
Figure 8 Market Dynamics
Figure 9 Market Share Analysis, By Key Player, 2013
Figure 10 Laboratory Workflow With Integrated Digital Imaging
Figure 11 Digital Pathology Market, By Product
Figure 12 Global Market Volume for Scanners, 2013–2018 (Units)
Figure 13 Market, By Application
Figure 14 Market, Geographical Ranking, 2013
Figure 15 Key Growth Strategies, 2011–2014
Figure 16 Key Players Focusing on New Product Launches, 2011–2014
Figure 17 Key Players Focusing on the Strategy of Agreements, Partnerships, and Collaborations, 2011–2014